90Y-ibritumomab tiuxetan (Zevalin) in heavily pretreated patients with mucosa associated lymphoid tissue lymphoma
about
90Y-ibritumomab tiuxetan (Zevalin) in heavily pretreated patients with mucosa associated lymphoid tissue lymphoma
description
scientific article published on 06 December 2010
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в грудні 2010
@uk
name
90Y-ibritumomab tiuxetan (Zeva ...... iated lymphoid tissue lymphoma
@en
90Y-ibritumomab tiuxetan
@nl
type
label
90Y-ibritumomab tiuxetan (Zeva ...... iated lymphoid tissue lymphoma
@en
90Y-ibritumomab tiuxetan
@nl
prefLabel
90Y-ibritumomab tiuxetan (Zeva ...... iated lymphoid tissue lymphoma
@en
90Y-ibritumomab tiuxetan
@nl
P2093
P1433
P1476
90Y-ibritumomab tiuxetan (Zeva ...... iated lymphoid tissue lymphoma
@en
P2093
Constanze Jonak
Harald Eidherr
Leonhard Muellauer
Markus Raderer
Marlene Troch
Martha Hoffmann
P356
10.3109/10428194.2010.534519
P577
2010-12-06T00:00:00Z